Estradiol Valerate/Dienogest

Margaret Rees
In: Drugs · 2002 · vol. 62(3) , pp. 505–506 · doi:10.2165/00003495-200262030-00008 · W2213789031
article OA: closed CC0 ⤵ 2 in-corpus citations
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06+body, 2026-06-07 ⓘ

This review discusses the drug estradiol valerate/dienogest, a combined oral contraceptive.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text ⓘ

This short paper citation entry in Drugs (2002) lists the article “Rees, M. Estradiol Valerate/Dienogest,” with bibliographic details, but provides no original study population, methods, results, or explicit findings in the provided text. It includes references about why women start and stop hormone replacement therapy and determinants of persistence with estrogen replacement, but the excerpt does not connect these to any measured outcomes for estradiol valerate/dienogest itself. The major limitation is that the full content needed to identify what was studied and what was concluded is not present here. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 584 characters · extracted from oa-doi-fallback · click to expand
References Hope S, Rees M. Why do British women start and stop hormone replacement therapy? Journal of the British Menopausal Society 1995; 1: 26–8 Pilon D, Castilloux AM, LeLorier J. Estrogen replacement therapy: determinants of persistence with treatment. Obstet Gynecol 2001; 97: 97–100 Author information Authors and Affiliations Rights and permissions About this article Cite this article Rees, M. Estradiol Valerate/Dienogest. Drugs 62, 505–506 (2002). https://doi.org/10.2165/00003495-200262030-00008 Published: Issue date: DOI: https://doi.org/10.2165/00003495-200262030-00008

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

References (2)

Cited by (2)

Source provenance

openalex
last seen: 2026-05-11T04:01:17.019605+00:00
License: CC0 · commercial use OK